Description
IGF::CT::IGF BLOOD AND BLOOD PRODUCTS/SERVICES
First action · last action
2013-10-01 · 2014-05-21
Transactions
2
First transaction's obligation
$403,690
Base + all options value (sum of deltas)
$373,690
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA25612D0363
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-10-01+$403,690= $403,690
- Mod P000012014-05-21-$30,000= $373,690
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-10-01 | +$403,690 | $403,690 | IGF::CT::IGF BLOOD AND BLOOD PRODUCTS/SERVICES |
| Mod P00001· FUNDING ONLY ACTION | 2014-05-21 | −$30,000 | $373,690 | IGF::CT::IGF BLOOD AND BLOOD PRODUCTS/SERVICES |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI SCFJBJWLMXT6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25626D0050 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C25626N0450 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $324,605 | FY2026 |
| 36C25626N0432 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $245,189 | FY2026 |
| 36C25626N0069 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $135,008 | FY2026 |
| 36C25625N0652 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $162,292 | FY2025 |
| 36C25625N0007 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $307,339 | FY2025 |
Other recipients under Q999 from 256-NETWORK CONTRACT OFFICE 16 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25617E0208 | INFIRMARY HEALTH SYSTEM, INC | 256-NETWORK CONTRACT OFFICE 16 | $6,077 | FY2016 |
| VA25617E0217 | COUNCIL ON AGING OF WEST FLORIDA | 256-NETWORK CONTRACT OFFICE 16 | $65,821 | FY2016 |
| VA25617E0212 | GULF SHORES ADULT DAY CARE, LLC | 256-NETWORK CONTRACT OFFICE 16 | $133,260 | FY2016 |
| VA25616J0013 | FRESENIUS MEDICAL CARE TULSA, LLC | 256-NETWORK CONTRACT OFFICE 16 | $78,464 | FY2016 |
| VA25615D0187 | TOTAL RENAL CARE, INC. | 256-NETWORK CONTRACT OFFICE 16 | $0 | FY2015 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25614J2531_3600_VA25612D0363_3600 · retrieved 2026-09-26.